Logo image of JAREN.OL

JAREN SPAREBANK (JAREN.OL) Stock Fundamental Analysis

OSL:JAREN - Euronext Oslo - NO0010359433 - Common Stock - Currency: NOK

358  0 (0%)

Fundamental Rating

3

JAREN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 99 industry peers in the Banks industry. JAREN has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, JAREN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year JAREN was profitable.
In the past year JAREN has reported a negative cash flow from operations.
In the past 5 years JAREN has always been profitable.
The reported operating cash flow has been mixed in the past 5 years: JAREN reported negative operating cash flow in multiple years.
JAREN.OL Yearly Net Income VS EBIT VS OCF VS FCFJAREN.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.76%, JAREN is in line with its industry, outperforming 49.46% of the companies in the same industry.
JAREN has a worse Return On Equity (5.50%) than 65.59% of its industry peers.
Industry RankSector Rank
ROA 0.76%
ROE 5.5%
ROIC N/A
ROA(3y)0.69%
ROA(5y)0.59%
ROE(3y)4.89%
ROE(5y)4.27%
ROIC(3y)N/A
ROIC(5y)N/A
JAREN.OL Yearly ROA, ROE, ROICJAREN.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

The Profit Margin of JAREN (25.53%) is better than 69.89% of its industry peers.
JAREN's Profit Margin has improved in the last couple of years.
JAREN does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 25.53%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y6.15%
PM growth 5Y3.14%
GM growth 3YN/A
GM growth 5YN/A
JAREN.OL Yearly Profit, Operating, Gross MarginsJAREN.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1

2. Health

2.1 Basic Checks

JAREN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, JAREN has about the same amount of shares outstanding.
The number of shares outstanding for JAREN has been reduced compared to 5 years ago.
The debt/assets ratio for JAREN is higher compared to a year ago.
JAREN.OL Yearly Shares OutstandingJAREN.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
JAREN.OL Yearly Total Debt VS Total AssetsJAREN.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

A Debt/Equity ratio of 1.47 is on the high side and indicates that JAREN has dependencies on debt financing.
The Debt to Equity ratio of JAREN (1.47) is better than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.47
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC5.68%
JAREN.OL Yearly LT Debt VS Equity VS FCFJAREN.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
JAREN.OL Yearly Current Assets VS Current LiabilitesJAREN.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.82% over the past year.
The Earnings Per Share has been growing by 10.82% on average over the past years. This is quite good.
The Revenue has grown by 8.93% in the past year. This is quite good.
Measured over the past years, JAREN shows a quite strong growth in Revenue. The Revenue has been growing by 8.57% on average per year.
EPS 1Y (TTM)11.82%
EPS 3Y19.83%
EPS 5Y10.82%
EPS Q2Q%-6.82%
Revenue 1Y (TTM)8.93%
Revenue growth 3Y14.87%
Revenue growth 5Y8.57%
Sales Q2Q%13.28%

3.2 Future

Based on estimates for the next years, JAREN will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.54% on average per year.
Based on estimates for the next years, JAREN will show a small growth in Revenue. The Revenue will grow by 6.81% on average per year.
EPS Next Y10.09%
EPS Next 2Y8.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.54%
Revenue Next 2Y6.27%
Revenue Next 3Y6.81%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
JAREN.OL Yearly Revenue VS EstimatesJAREN.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
JAREN.OL Yearly EPS VS EstimatesJAREN.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10 20 30

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.72, JAREN is valued correctly.
Based on the Price/Earnings ratio, JAREN is valued more expensive than 82.80% of the companies in the same industry.
When comparing the Price/Earnings ratio of JAREN to the average of the S&P500 Index (29.35), we can say JAREN is valued rather cheaply.
A Price/Forward Earnings ratio of 10.88 indicates a reasonable valuation of JAREN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of JAREN indicates a slightly more expensive valuation: JAREN is more expensive than 62.37% of the companies listed in the same industry.
JAREN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.10.
Industry RankSector Rank
PE 12.72
Fwd PE 10.88
JAREN.OL Price Earnings VS Forward Price EarningsJAREN.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
JAREN.OL Per share dataJAREN.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200 300 400 500

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.26
PEG (5Y)1.18
EPS Next 2Y8.54%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.59%, JAREN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.06, JAREN pays a bit more dividend than its industry peers.
JAREN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 5.59%

5.2 History

The dividend of JAREN is nicely growing with an annual growth rate of 31.60%!
Dividend Growth(5Y)31.6%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

JAREN pays out 100.42% of its income as dividend. This is not a sustainable payout ratio.
JAREN's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP100.42%
EPS Next 2Y8.54%
EPS Next 3YN/A
JAREN.OL Yearly Income VS Free CF VS DividendJAREN.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M
JAREN.OL Dividend Payout.JAREN.OL Dividend Payout, showing the Payout Ratio.JAREN.OL Dividend Payout.PayoutRetained Earnings

JAREN SPAREBANK

OSL:JAREN (3/7/2025, 7:00:00 PM)

358

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)02-10 2025-02-10/amc
Earnings (Next)05-15 2025-05-15
Inst Owners7.07%
Inst Owner ChangeN/A
Ins Owners5%
Ins Owner ChangeN/A
Market Cap1.76B
Analysts40
Price Target382.5 (6.84%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.59%
Yearly Dividend29.21
Dividend Growth(5Y)31.6%
DP100.42%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.7%
Min Revenue beat(2)5.58%
Max Revenue beat(2)5.81%
Revenue beat(4)2
Avg Revenue beat(4)1.02%
Min Revenue beat(4)-4.63%
Max Revenue beat(4)5.81%
Revenue beat(8)4
Avg Revenue beat(8)3.84%
Revenue beat(12)8
Avg Revenue beat(12)8.25%
Revenue beat(16)12
Avg Revenue beat(16)9.42%
PT rev (1m)5.63%
PT rev (3m)21.36%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)11.83%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)7.86%
Revenue NY rev (3m)7.86%
Valuation
Industry RankSector Rank
PE 12.72
Fwd PE 10.88
P/S 3.14
P/FCF N/A
P/OCF N/A
P/B 0.68
P/tB 0.68
EV/EBITDA N/A
EPS(TTM)28.14
EY7.86%
EPS(NY)32.92
Fwd EY9.2%
FCF(TTM)-27.31
FCFYN/A
OCF(TTM)-25.79
OCFYN/A
SpS114.01
BVpS529.18
TBVpS529.18
PEG (NY)1.26
PEG (5Y)1.18
Profitability
Industry RankSector Rank
ROA 0.76%
ROE 5.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 25.53%
GM N/A
FCFM N/A
ROA(3y)0.69%
ROA(5y)0.59%
ROE(3y)4.89%
ROE(5y)4.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y6.15%
PM growth 5Y3.14%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 1.47
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC5.68%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.21%
Cap/Sales(5y)1.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.82%
EPS 3Y19.83%
EPS 5Y10.82%
EPS Q2Q%-6.82%
EPS Next Y10.09%
EPS Next 2Y8.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.93%
Revenue growth 3Y14.87%
Revenue growth 5Y8.57%
Sales Q2Q%13.28%
Revenue Next Year6.54%
Revenue Next 2Y6.27%
Revenue Next 3Y6.81%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-203.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-242.5%
OCF growth 3YN/A
OCF growth 5YN/A